Ankylosing Spondylitis Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Ankylosing Spondylitis Market
1.1. Definition and Scope
1.1.1. Definition of Ankylosing Spondylitis
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Ankylosing Spondylitis Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Ankylosing Spondylitis Market By Treatment Types
1.2.3. Ankylosing Spondylitis Market By End User
1.2.4. Ankylosing Spondylitis Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Ankylosing Spondylitis Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Ankylosing Spondylitis Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Ankylosing Spondylitis Market By Treatment Types
5.1. Introduction
5.2. Ankylosing Spondylitis Revenue By Treatment Types
5.2.1. Ankylosing Spondylitis Revenue (USD Billion) and Forecast, By Treatment Types, 2020-2032
5.2.2. Medication
5.2.2.1. Medication Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. IL-17 Inhibitors
5.2.2.2.1. IL-17 Inhibitors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
5.2.2.3.1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.4. TNF Inhibitors
5.2.2.4.1. TNF Inhibitors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.5. Others
5.2.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Surgery
5.2.3.1. SurgeryMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Therapy
5.2.4.1. TherapyMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Ankylosing Spondylitis Market By End User
6.1. Introduction
6.2. Ankylosing Spondylitis Revenue By End User
6.2.1. Ankylosing Spondylitis Revenue (USD Billion) and Forecast, By End User, 2020-2032
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Clinics
6.2.3.1. ClinicsMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Ambulatory Surgery Centres
6.2.4.1. Ambulatory Surgery Centres Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Others
6.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Ankylosing Spondylitis Market By Country
7.1. North America Ankylosing Spondylitis Market Overview
7.2. U.S.
7.2.1. U.S. Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
7.2.2. U.S. Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
7.3. Canada
7.3.1. Canada Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
7.3.2. Canada Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Ankylosing Spondylitis Market By Country
8.1. Europe Ankylosing Spondylitis Market Overview
8.2. U.K.
8.2.1. U.K. Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
8.2.2. U.K. Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
8.3. Germany
8.3.1. Germany Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
8.3.2. Germany Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
8.4. France
8.4.1. France Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
8.4.2. France Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
8.5. Spain
8.5.1. Spain Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
8.5.2. Spain Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
8.6.2. Rest of Europe Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Ankylosing Spondylitis Market By Country
9.1. Asia Pacific Ankylosing Spondylitis Market Overview
9.2. China
9.2.1. China Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
9.2.2. China Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.3. Japan
9.3.1. Japan Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
9.3.2. Japan Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.4. India
9.4.1. India Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
9.4.2. India Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.5. Australia
9.5.1. Australia Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
9.5.2. Australia Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.6. South Korea
9.6.1. South Korea Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
9.6.2. South Korea Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
9.7.2. Rest of Asia-Pacific Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Ankylosing Spondylitis Market By Country
10.1. Latin America Ankylosing Spondylitis Market Overview
10.2. Brazil
10.2.1. Brazil Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
10.2.2. Brazil Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
10.3. Mexico
10.3.1. Mexico Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
10.3.2. Mexico Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
10.4.2. Rest of Latin America Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Ankylosing Spondylitis Market By Country
11.1. Middle East & Africa Ankylosing Spondylitis Market Overview
11.2. GCC
11.2.1. GCC Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
11.2.2. GCC Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
11.3. South Africa
11.3.1. South Africa Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
11.3.2. South Africa Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Ankylosing Spondylitis Revenue (USD Billion) and Forecast By Treatment Types, 2020-2032
11.4.2. Rest of Middle East & Africa Ankylosing Spondylitis Revenue (USD Billion) and Forecast By End User, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Ankylosing Spondylitis Market
12.1. Ankylosing Spondylitis Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Ankylosing Spondylitis Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. AbbVie Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2022
13.1.3.2. AbbVie Inc. 2022 Ankylosing Spondylitis Business Regional Distribution
13.1.4. Product/Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Amgen Inc.
13.3. Pfizer Inc.
13.4. Novartis AG
13.5. Eli Lilly and Company
13.6. Johnson & Johnson
13.7. UCB S.A.
13.8. Boehringer Ingelheim Pharmaceuticals, Inc.
13.9. Bristol Myers Squibb
13.10. Merck & Co., Inc.
13.11. GlaxoSmithKline plc (GSK)
Frequently Asked Questions
What was the market size of the global ankylosing spondylitis in 2022?
The market size of ankylosing spondylitis was USD 5.1 Billion in 2022.
What is the CAGR of the global ankylosing spondylitis market from 2023 to 2032?
The CAGR of ankylosing spondylitis is 6.5% during the analysis period of 2023 to 2032.
Which are the key players in the ankylosing spondylitis market?
The key players operating in the global market are including AbbVie Inc., Amgen Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Johnson & Johnson, UCB S.A., Boehringer Ingelheim Pharmaceuticals, Inc., Bristol Myers Squibb, Merck & Co., Inc., and GlaxoSmithKline plc (GSK).
Which region dominated the global ankylosing spondylitis market share?
North America held the dominating position in ankylosing spondylitis industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of ankylosing spondylitis during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global ankylosing spondylitis industry?
The current trends and dynamics in the ankylosing spondylitis market growth include increasing prevalence and diagnosis of ankylosing spondylitis, advancements in biologic therapies and treatment options, and growing aging population susceptible to autoimmune diseases.
Which treatment types held the maximum share in 2022?
The medication treatment types held the maximum share of the ankylosing spondylitis industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
